Prophylactic lidocaine: Uncertain benefits in emergency settings

Jonathan Borak, Suzanne Veilleux

Research output: Contribution to journalArticle

Abstract

The need to determine whether prophylactic lidocaine has any therapeutic value is generally recognized, and further investigations have been urged:. A carefully designed clinical trial of routine lidocaine administration should be carried out to provide definitive information for the physician treating patients who have had myocardial infarction. Such trials should begin immediately, in view of the magnitude of the problem and the fact that routine prophylaxis of arrhythmias after myocardial infarction is not common policy. Such a study, if well designed, can answer the question ...33. Carefully designed trials must be conducted with patients included in the study as soon as possible after the onset of symptoms, preferably during the prehospital phase, and the medication must be administered in a random-controlled fashion. Although these requirements pose no extraordinary problems of research design and method, they lead to prohibiting ethical conflicts. Without resolving these conflicts, through the elaboration of acceptable standards which bypass traditional informed consent, the value of lidocaine prophylaxis will remain uncertain, as will the many other emergency therapeutic maneuvers of unproven effectiveness.

Original languageEnglish (US)
Pages (from-to)490-492
Number of pages3
JournalAnnals of Emergency Medicine
Volume11
Issue number9
DOIs
StatePublished - 1982
Externally publishedYes

Fingerprint

Lidocaine
Emergencies
Myocardial Infarction
Informed Consent
Cardiac Arrhythmias
Research Design
Clinical Trials
Physicians
Therapeutics

Keywords

  • lidocaine
  • medical ethics, research
  • research, design

ASJC Scopus subject areas

  • Emergency Medicine

Cite this

Prophylactic lidocaine : Uncertain benefits in emergency settings. / Borak, Jonathan; Veilleux, Suzanne.

In: Annals of Emergency Medicine, Vol. 11, No. 9, 1982, p. 490-492.

Research output: Contribution to journalArticle

Borak, Jonathan ; Veilleux, Suzanne. / Prophylactic lidocaine : Uncertain benefits in emergency settings. In: Annals of Emergency Medicine. 1982 ; Vol. 11, No. 9. pp. 490-492.
@article{444a55beaaf643679f3d845e7b0b7c74,
title = "Prophylactic lidocaine: Uncertain benefits in emergency settings",
abstract = "The need to determine whether prophylactic lidocaine has any therapeutic value is generally recognized, and further investigations have been urged:. A carefully designed clinical trial of routine lidocaine administration should be carried out to provide definitive information for the physician treating patients who have had myocardial infarction. Such trials should begin immediately, in view of the magnitude of the problem and the fact that routine prophylaxis of arrhythmias after myocardial infarction is not common policy. Such a study, if well designed, can answer the question ...33. Carefully designed trials must be conducted with patients included in the study as soon as possible after the onset of symptoms, preferably during the prehospital phase, and the medication must be administered in a random-controlled fashion. Although these requirements pose no extraordinary problems of research design and method, they lead to prohibiting ethical conflicts. Without resolving these conflicts, through the elaboration of acceptable standards which bypass traditional informed consent, the value of lidocaine prophylaxis will remain uncertain, as will the many other emergency therapeutic maneuvers of unproven effectiveness.",
keywords = "lidocaine, medical ethics, research, research, design",
author = "Jonathan Borak and Suzanne Veilleux",
year = "1982",
doi = "10.1016/S0196-0644(82)80071-1",
language = "English (US)",
volume = "11",
pages = "490--492",
journal = "Annals of Emergency Medicine",
issn = "0196-0644",
publisher = "Mosby Inc.",
number = "9",

}

TY - JOUR

T1 - Prophylactic lidocaine

T2 - Uncertain benefits in emergency settings

AU - Borak, Jonathan

AU - Veilleux, Suzanne

PY - 1982

Y1 - 1982

N2 - The need to determine whether prophylactic lidocaine has any therapeutic value is generally recognized, and further investigations have been urged:. A carefully designed clinical trial of routine lidocaine administration should be carried out to provide definitive information for the physician treating patients who have had myocardial infarction. Such trials should begin immediately, in view of the magnitude of the problem and the fact that routine prophylaxis of arrhythmias after myocardial infarction is not common policy. Such a study, if well designed, can answer the question ...33. Carefully designed trials must be conducted with patients included in the study as soon as possible after the onset of symptoms, preferably during the prehospital phase, and the medication must be administered in a random-controlled fashion. Although these requirements pose no extraordinary problems of research design and method, they lead to prohibiting ethical conflicts. Without resolving these conflicts, through the elaboration of acceptable standards which bypass traditional informed consent, the value of lidocaine prophylaxis will remain uncertain, as will the many other emergency therapeutic maneuvers of unproven effectiveness.

AB - The need to determine whether prophylactic lidocaine has any therapeutic value is generally recognized, and further investigations have been urged:. A carefully designed clinical trial of routine lidocaine administration should be carried out to provide definitive information for the physician treating patients who have had myocardial infarction. Such trials should begin immediately, in view of the magnitude of the problem and the fact that routine prophylaxis of arrhythmias after myocardial infarction is not common policy. Such a study, if well designed, can answer the question ...33. Carefully designed trials must be conducted with patients included in the study as soon as possible after the onset of symptoms, preferably during the prehospital phase, and the medication must be administered in a random-controlled fashion. Although these requirements pose no extraordinary problems of research design and method, they lead to prohibiting ethical conflicts. Without resolving these conflicts, through the elaboration of acceptable standards which bypass traditional informed consent, the value of lidocaine prophylaxis will remain uncertain, as will the many other emergency therapeutic maneuvers of unproven effectiveness.

KW - lidocaine

KW - medical ethics, research

KW - research, design

UR - http://www.scopus.com/inward/record.url?scp=49049143236&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=49049143236&partnerID=8YFLogxK

U2 - 10.1016/S0196-0644(82)80071-1

DO - 10.1016/S0196-0644(82)80071-1

M3 - Article

AN - SCOPUS:49049143236

VL - 11

SP - 490

EP - 492

JO - Annals of Emergency Medicine

JF - Annals of Emergency Medicine

SN - 0196-0644

IS - 9

ER -